Bank of New York Mellon’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
SCM
N
Bank of New York Mellon's PRAX Position: Q2 2026 in Review
Bank of New York Mellon reduced its Praxis Precision Medicines (PRAX) stake by 1.9% in Q2 2026, selling an estimated $529K and leaving 85,376 shares worth $28.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1405.
Bank of New York Mellon first reported a position in PRAX in Q4 2020 and has held it in 21 quarters since. 123 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Bank of New York Mellon held 85,376 shares of Praxis Precision Medicines worth $28.6M as of Q2 2026.
- Bank of New York Mellon sold 1,671 Praxis Precision Medicines shares in Q2 2026, an estimated $529K.
- Praxis Precision Medicines made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1405 holding.
- Bank of New York Mellon first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 21 quarters since.
- 123 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.